| 1.6 |
4.8 |
GO:0006601 |
creatine biosynthetic process(GO:0006601) |
| 1.1 |
3.4 |
GO:0043379 |
memory T cell differentiation(GO:0043379) |
| 1.1 |
1.1 |
GO:0032911 |
negative regulation of transforming growth factor beta1 production(GO:0032911) |
| 1.0 |
3.0 |
GO:0015910 |
peroxisomal long-chain fatty acid import(GO:0015910) |
| 0.9 |
3.5 |
GO:0032489 |
regulation of Cdc42 protein signal transduction(GO:0032489) |
| 0.9 |
3.5 |
GO:0016340 |
calcium-dependent cell-matrix adhesion(GO:0016340) |
| 0.8 |
2.5 |
GO:0035928 |
rRNA import into mitochondrion(GO:0035928) |
| 0.8 |
2.3 |
GO:0030827 |
negative regulation of cGMP metabolic process(GO:0030824) negative regulation of cGMP biosynthetic process(GO:0030827) negative regulation of guanylate cyclase activity(GO:0031283) |
| 0.8 |
3.0 |
GO:0071475 |
cellular hyperosmotic salinity response(GO:0071475) |
| 0.7 |
2.1 |
GO:0018008 |
N-terminal peptidyl-glycine N-myristoylation(GO:0018008) peptidyl-glycine modification(GO:0018201) |
| 0.7 |
2.8 |
GO:0042373 |
vitamin K metabolic process(GO:0042373) |
| 0.7 |
2.8 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.7 |
3.4 |
GO:0030205 |
dermatan sulfate metabolic process(GO:0030205) |
| 0.6 |
1.9 |
GO:0043988 |
histone H3-S28 phosphorylation(GO:0043988) |
| 0.6 |
3.1 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.6 |
1.3 |
GO:0072223 |
metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
| 0.6 |
8.0 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.6 |
2.3 |
GO:1904425 |
negative regulation of GTP binding(GO:1904425) |
| 0.6 |
3.4 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.6 |
3.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.5 |
1.6 |
GO:0034447 |
very-low-density lipoprotein particle clearance(GO:0034447) |
| 0.5 |
2.2 |
GO:0007066 |
female meiosis sister chromatid cohesion(GO:0007066) |
| 0.5 |
3.2 |
GO:0016557 |
peroxisome membrane biogenesis(GO:0016557) |
| 0.5 |
4.2 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.5 |
5.0 |
GO:2000051 |
negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
| 0.5 |
1.5 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.5 |
2.0 |
GO:0021564 |
glossopharyngeal nerve development(GO:0021563) vagus nerve development(GO:0021564) |
| 0.5 |
1.9 |
GO:1901642 |
purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
| 0.5 |
1.4 |
GO:0097155 |
fasciculation of sensory neuron axon(GO:0097155) |
| 0.5 |
1.4 |
GO:0043696 |
dedifferentiation(GO:0043696) cell dedifferentiation(GO:0043697) |
| 0.5 |
3.6 |
GO:0038028 |
insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
| 0.5 |
1.8 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.5 |
1.4 |
GO:1901420 |
negative regulation of response to alcohol(GO:1901420) |
| 0.4 |
1.8 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.4 |
2.2 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.4 |
1.3 |
GO:0000710 |
meiotic mismatch repair(GO:0000710) |
| 0.4 |
3.1 |
GO:0015862 |
uridine transport(GO:0015862) pyrimidine nucleoside transport(GO:0015864) |
| 0.4 |
1.3 |
GO:2000402 |
negative regulation of lymphocyte migration(GO:2000402) |
| 0.4 |
3.1 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.4 |
0.9 |
GO:0034382 |
chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.4 |
1.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.4 |
2.5 |
GO:0050861 |
positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.4 |
1.7 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.4 |
1.3 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.4 |
2.5 |
GO:2000049 |
positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.4 |
1.6 |
GO:0036451 |
cap mRNA methylation(GO:0036451) |
| 0.4 |
1.2 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.4 |
5.3 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.4 |
1.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.4 |
1.2 |
GO:0002447 |
eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
| 0.4 |
0.4 |
GO:0006642 |
triglyceride mobilization(GO:0006642) |
| 0.4 |
1.2 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.4 |
1.5 |
GO:0007039 |
protein catabolic process in the vacuole(GO:0007039) |
| 0.4 |
1.2 |
GO:0016598 |
protein arginylation(GO:0016598) |
| 0.4 |
1.5 |
GO:0097298 |
regulation of nucleus size(GO:0097298) |
| 0.4 |
1.9 |
GO:1902837 |
amino acid import into cell(GO:1902837) |
| 0.4 |
3.7 |
GO:2001214 |
positive regulation of vasculogenesis(GO:2001214) |
| 0.4 |
1.1 |
GO:0046340 |
diacylglycerol catabolic process(GO:0046340) |
| 0.4 |
1.1 |
GO:0060854 |
patterning of lymph vessels(GO:0060854) |
| 0.4 |
2.6 |
GO:0016127 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 |
3.6 |
GO:0048199 |
vesicle targeting, to, from or within Golgi(GO:0048199) |
| 0.4 |
1.1 |
GO:0002678 |
positive regulation of chronic inflammatory response(GO:0002678) |
| 0.4 |
1.1 |
GO:0035910 |
ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
| 0.3 |
1.4 |
GO:0035609 |
C-terminal protein deglutamylation(GO:0035609) |
| 0.3 |
2.8 |
GO:1904738 |
vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) |
| 0.3 |
4.8 |
GO:0035493 |
SNARE complex assembly(GO:0035493) |
| 0.3 |
1.0 |
GO:0042196 |
dichloromethane metabolic process(GO:0018900) chlorinated hydrocarbon metabolic process(GO:0042196) halogenated hydrocarbon metabolic process(GO:0042197) |
| 0.3 |
1.4 |
GO:0045054 |
constitutive secretory pathway(GO:0045054) |
| 0.3 |
2.4 |
GO:1902669 |
positive regulation of axon extension involved in axon guidance(GO:0048842) positive regulation of axon guidance(GO:1902669) |
| 0.3 |
1.7 |
GO:0015788 |
UDP-N-acetylglucosamine transport(GO:0015788) |
| 0.3 |
1.0 |
GO:0046168 |
glycerol-3-phosphate catabolic process(GO:0046168) |
| 0.3 |
0.7 |
GO:0098528 |
skeletal muscle fiber differentiation(GO:0098528) |
| 0.3 |
0.7 |
GO:0072008 |
glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
| 0.3 |
1.6 |
GO:0042538 |
hyperosmotic salinity response(GO:0042538) |
| 0.3 |
1.3 |
GO:2000047 |
regulation of cell-cell adhesion mediated by cadherin(GO:2000047) |
| 0.3 |
1.3 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.3 |
1.0 |
GO:1900149 |
positive regulation of Schwann cell migration(GO:1900149) |
| 0.3 |
0.3 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.3 |
0.9 |
GO:0097051 |
glutamate secretion, neurotransmission(GO:0061535) establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.3 |
1.6 |
GO:0042167 |
heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.3 |
0.9 |
GO:1903903 |
regulation of establishment of T cell polarity(GO:1903903) |
| 0.3 |
0.9 |
GO:1904742 |
protein poly-ADP-ribosylation(GO:0070212) regulation of telomeric DNA binding(GO:1904742) |
| 0.3 |
0.9 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.3 |
0.9 |
GO:0090327 |
negative regulation of locomotion involved in locomotory behavior(GO:0090327) |
| 0.3 |
1.8 |
GO:0030643 |
cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.3 |
0.9 |
GO:1901675 |
negative regulation of histone H3-K27 acetylation(GO:1901675) |
| 0.3 |
4.7 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.3 |
0.9 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.3 |
1.2 |
GO:2000525 |
regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
| 0.3 |
0.9 |
GO:0019482 |
beta-alanine metabolic process(GO:0019482) |
| 0.3 |
0.9 |
GO:0030327 |
prenylated protein catabolic process(GO:0030327) |
| 0.3 |
0.9 |
GO:0006592 |
ornithine biosynthetic process(GO:0006592) |
| 0.3 |
0.6 |
GO:0003273 |
cell migration involved in endocardial cushion formation(GO:0003273) |
| 0.3 |
0.9 |
GO:0006001 |
fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.3 |
0.9 |
GO:0042977 |
activation of JAK2 kinase activity(GO:0042977) |
| 0.3 |
0.8 |
GO:0018125 |
peptidyl-cysteine methylation(GO:0018125) |
| 0.3 |
0.6 |
GO:0014891 |
striated muscle atrophy(GO:0014891) |
| 0.3 |
1.7 |
GO:0015879 |
carnitine transport(GO:0015879) |
| 0.3 |
0.8 |
GO:0061743 |
motor learning(GO:0061743) |
| 0.3 |
1.9 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.3 |
0.8 |
GO:0042560 |
10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 0.3 |
1.3 |
GO:0045541 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
1.6 |
GO:0071415 |
cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
| 0.3 |
1.6 |
GO:0003383 |
apical constriction(GO:0003383) |
| 0.3 |
0.8 |
GO:0034162 |
toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.3 |
0.3 |
GO:0072368 |
regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter(GO:0072368) |
| 0.3 |
0.8 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) |
| 0.2 |
1.0 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.2 |
1.4 |
GO:0032804 |
negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) |
| 0.2 |
0.7 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.2 |
2.1 |
GO:0075522 |
IRES-dependent viral translational initiation(GO:0075522) |
| 0.2 |
0.5 |
GO:0021814 |
cell motility involved in cerebral cortex radial glia guided migration(GO:0021814) |
| 0.2 |
0.9 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.2 |
0.7 |
GO:0018103 |
protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.2 |
0.9 |
GO:0015888 |
thiamine transport(GO:0015888) |
| 0.2 |
3.5 |
GO:2001014 |
regulation of skeletal muscle cell differentiation(GO:2001014) |
| 0.2 |
0.9 |
GO:0099624 |
regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
| 0.2 |
0.9 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.2 |
0.9 |
GO:0035934 |
corticosterone secretion(GO:0035934) |
| 0.2 |
3.5 |
GO:0071378 |
growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.2 |
1.6 |
GO:0000042 |
protein targeting to Golgi(GO:0000042) |
| 0.2 |
0.9 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.2 |
0.7 |
GO:0006558 |
L-phenylalanine metabolic process(GO:0006558) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) |
| 0.2 |
0.7 |
GO:2000409 |
positive regulation of T cell extravasation(GO:2000409) |
| 0.2 |
0.9 |
GO:0070278 |
extracellular matrix constituent secretion(GO:0070278) |
| 0.2 |
1.4 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 |
0.7 |
GO:0060800 |
regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.2 |
0.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
1.8 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.2 |
1.8 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.2 |
0.4 |
GO:1901740 |
negative regulation of myoblast fusion(GO:1901740) |
| 0.2 |
0.6 |
GO:0046104 |
thymidine metabolic process(GO:0046104) |
| 0.2 |
0.4 |
GO:0002034 |
angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001998) regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
| 0.2 |
0.8 |
GO:0070589 |
cell wall mannoprotein biosynthetic process(GO:0000032) mannoprotein metabolic process(GO:0006056) mannoprotein biosynthetic process(GO:0006057) cell wall glycoprotein biosynthetic process(GO:0031506) cell wall biogenesis(GO:0042546) cell wall macromolecule metabolic process(GO:0044036) cell wall macromolecule biosynthetic process(GO:0044038) chain elongation of O-linked mannose residue(GO:0044845) cellular component macromolecule biosynthetic process(GO:0070589) cell wall organization or biogenesis(GO:0071554) |
| 0.2 |
1.2 |
GO:0090383 |
phagosome acidification(GO:0090383) |
| 0.2 |
0.6 |
GO:0061153 |
trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
| 0.2 |
0.4 |
GO:0042505 |
tyrosine phosphorylation of Stat6 protein(GO:0042505) regulation of tyrosine phosphorylation of Stat6 protein(GO:0042525) |
| 0.2 |
1.2 |
GO:0048549 |
positive regulation of pinocytosis(GO:0048549) |
| 0.2 |
0.6 |
GO:0044340 |
canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 |
1.8 |
GO:0071569 |
protein ufmylation(GO:0071569) |
| 0.2 |
0.6 |
GO:0043181 |
vacuolar sequestering(GO:0043181) |
| 0.2 |
1.4 |
GO:0007342 |
fusion of sperm to egg plasma membrane(GO:0007342) |
| 0.2 |
0.4 |
GO:0070318 |
positive regulation of G0 to G1 transition(GO:0070318) |
| 0.2 |
0.8 |
GO:0070305 |
response to cGMP(GO:0070305) cellular response to cGMP(GO:0071321) |
| 0.2 |
1.0 |
GO:0001561 |
fatty acid alpha-oxidation(GO:0001561) |
| 0.2 |
1.9 |
GO:0090557 |
establishment of endothelial intestinal barrier(GO:0090557) |
| 0.2 |
0.6 |
GO:0034135 |
regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
| 0.2 |
0.8 |
GO:0019254 |
carnitine metabolic process, CoA-linked(GO:0019254) |
| 0.2 |
0.2 |
GO:0001844 |
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
| 0.2 |
0.2 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 |
0.8 |
GO:0030382 |
sperm mitochondrion organization(GO:0030382) |
| 0.2 |
3.2 |
GO:0048240 |
sperm capacitation(GO:0048240) |
| 0.2 |
1.3 |
GO:0042756 |
drinking behavior(GO:0042756) |
| 0.2 |
1.9 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 |
1.3 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.2 |
0.7 |
GO:0046469 |
platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
| 0.2 |
0.6 |
GO:0030210 |
heparin biosynthetic process(GO:0030210) |
| 0.2 |
2.2 |
GO:0045717 |
negative regulation of fatty acid biosynthetic process(GO:0045717) |
| 0.2 |
2.2 |
GO:0046686 |
response to cadmium ion(GO:0046686) |
| 0.2 |
0.7 |
GO:0019276 |
UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 |
0.7 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.2 |
0.5 |
GO:0001193 |
maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.2 |
0.7 |
GO:0036265 |
RNA (guanine-N7)-methylation(GO:0036265) |
| 0.2 |
3.2 |
GO:0003009 |
skeletal muscle contraction(GO:0003009) |
| 0.2 |
0.5 |
GO:0090324 |
negative regulation of oxidative phosphorylation(GO:0090324) |
| 0.2 |
0.8 |
GO:1902083 |
negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.2 |
1.8 |
GO:1902459 |
positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 |
1.3 |
GO:0003062 |
regulation of heart rate by chemical signal(GO:0003062) |
| 0.2 |
1.2 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 |
0.5 |
GO:0051006 |
positive regulation of lipoprotein lipase activity(GO:0051006) |
| 0.2 |
0.5 |
GO:0051342 |
regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
| 0.2 |
0.5 |
GO:2000598 |
regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
| 0.2 |
0.7 |
GO:0034454 |
microtubule anchoring at centrosome(GO:0034454) |
| 0.2 |
0.2 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
0.5 |
GO:0036500 |
ATF6-mediated unfolded protein response(GO:0036500) |
| 0.2 |
1.8 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) |
| 0.2 |
1.1 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.2 |
1.7 |
GO:0003215 |
cardiac right ventricle morphogenesis(GO:0003215) |
| 0.2 |
0.8 |
GO:0033275 |
actin-myosin filament sliding(GO:0033275) |
| 0.2 |
1.1 |
GO:0031848 |
protection from non-homologous end joining at telomere(GO:0031848) |
| 0.2 |
1.1 |
GO:0035735 |
intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.2 |
0.5 |
GO:0060754 |
positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.2 |
0.3 |
GO:1902995 |
regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
| 0.2 |
0.5 |
GO:0030862 |
regulation of polarized epithelial cell differentiation(GO:0030860) positive regulation of polarized epithelial cell differentiation(GO:0030862) |
| 0.2 |
3.3 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.1 |
1.2 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
2.4 |
GO:0006744 |
ubiquinone biosynthetic process(GO:0006744) |
| 0.1 |
0.3 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.1 |
GO:0035927 |
RNA import into mitochondrion(GO:0035927) |
| 0.1 |
2.9 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.1 |
2.2 |
GO:0002115 |
store-operated calcium entry(GO:0002115) |
| 0.1 |
5.2 |
GO:0034314 |
Arp2/3 complex-mediated actin nucleation(GO:0034314) |
| 0.1 |
0.6 |
GO:0097494 |
regulation of vesicle size(GO:0097494) |
| 0.1 |
0.4 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
| 0.1 |
0.6 |
GO:0043652 |
engulfment of apoptotic cell(GO:0043652) |
| 0.1 |
1.0 |
GO:0006290 |
pyrimidine dimer repair(GO:0006290) |
| 0.1 |
0.4 |
GO:0021933 |
radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.1 |
0.6 |
GO:0072015 |
glomerular visceral epithelial cell development(GO:0072015) glomerular epithelial cell development(GO:0072310) |
| 0.1 |
0.8 |
GO:0043297 |
apical junction assembly(GO:0043297) |
| 0.1 |
0.1 |
GO:0072338 |
creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
| 0.1 |
0.3 |
GO:1905154 |
negative regulation of membrane invagination(GO:1905154) |
| 0.1 |
0.3 |
GO:0061511 |
centriole elongation(GO:0061511) |
| 0.1 |
0.5 |
GO:0038128 |
ERBB2 signaling pathway(GO:0038128) |
| 0.1 |
0.5 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.5 |
GO:2000587 |
regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.3 |
GO:0003278 |
apoptotic process involved in heart morphogenesis(GO:0003278) |
| 0.1 |
0.4 |
GO:1904177 |
regulation of adipose tissue development(GO:1904177) |
| 0.1 |
0.5 |
GO:2000346 |
negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.1 |
1.1 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.1 |
1.2 |
GO:0070475 |
rRNA base methylation(GO:0070475) |
| 0.1 |
0.7 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.1 |
1.3 |
GO:1903301 |
positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 |
0.7 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.1 |
0.5 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.1 |
0.3 |
GO:0021943 |
formation of radial glial scaffolds(GO:0021943) |
| 0.1 |
0.5 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.1 |
0.3 |
GO:0046391 |
5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
| 0.1 |
0.3 |
GO:1902445 |
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.1 |
0.3 |
GO:1903998 |
regulation of eating behavior(GO:1903998) |
| 0.1 |
1.0 |
GO:0090219 |
negative regulation of lipid kinase activity(GO:0090219) |
| 0.1 |
0.7 |
GO:0042148 |
strand invasion(GO:0042148) |
| 0.1 |
0.1 |
GO:0008582 |
regulation of synaptic growth at neuromuscular junction(GO:0008582) |
| 0.1 |
0.4 |
GO:0042908 |
xenobiotic transport(GO:0042908) |
| 0.1 |
1.6 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.1 |
1.0 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.1 |
0.8 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 0.1 |
0.4 |
GO:0046900 |
tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 |
0.2 |
GO:0071677 |
positive regulation of mononuclear cell migration(GO:0071677) |
| 0.1 |
0.1 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.1 |
1.9 |
GO:2000096 |
positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
| 0.1 |
0.5 |
GO:0042448 |
progesterone metabolic process(GO:0042448) |
| 0.1 |
0.8 |
GO:0002591 |
positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
| 0.1 |
0.8 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.1 |
0.4 |
GO:0090427 |
embryonic nail plate morphogenesis(GO:0035880) activation of meiosis(GO:0090427) |
| 0.1 |
0.6 |
GO:0010991 |
regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.1 |
0.6 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.2 |
GO:0033034 |
positive regulation of myeloid cell apoptotic process(GO:0033034) |
| 0.1 |
0.5 |
GO:0034379 |
very-low-density lipoprotein particle assembly(GO:0034379) |
| 0.1 |
0.2 |
GO:2001212 |
regulation of vasculogenesis(GO:2001212) |
| 0.1 |
0.9 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.1 |
1.9 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.1 |
1.0 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 |
0.3 |
GO:0060527 |
prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
| 0.1 |
0.7 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.1 |
0.3 |
GO:0045041 |
protein import into mitochondrial intermembrane space(GO:0045041) |
| 0.1 |
0.2 |
GO:0010730 |
negative regulation of hydrogen peroxide metabolic process(GO:0010727) negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
| 0.1 |
0.4 |
GO:0070127 |
tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
| 0.1 |
0.3 |
GO:0071649 |
regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
| 0.1 |
0.4 |
GO:0034374 |
low-density lipoprotein particle remodeling(GO:0034374) |
| 0.1 |
0.6 |
GO:1902373 |
negative regulation of mRNA catabolic process(GO:1902373) |
| 0.1 |
0.4 |
GO:0097343 |
ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
| 0.1 |
0.8 |
GO:0009181 |
purine nucleoside diphosphate catabolic process(GO:0009137) purine ribonucleoside diphosphate catabolic process(GO:0009181) |
| 0.1 |
0.6 |
GO:0097368 |
establishment of Sertoli cell barrier(GO:0097368) |
| 0.1 |
0.3 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.1 |
0.1 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.2 |
GO:2000352 |
negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.1 |
1.7 |
GO:0050879 |
multicellular organismal movement(GO:0050879) musculoskeletal movement(GO:0050881) |
| 0.1 |
0.1 |
GO:2001269 |
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
| 0.1 |
0.2 |
GO:0021764 |
amygdala development(GO:0021764) |
| 0.1 |
0.7 |
GO:0016139 |
glycoside catabolic process(GO:0016139) |
| 0.1 |
1.6 |
GO:0032967 |
positive regulation of collagen biosynthetic process(GO:0032967) |
| 0.1 |
0.5 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.1 |
0.3 |
GO:0006556 |
S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 |
0.3 |
GO:2000015 |
regulation of determination of dorsal identity(GO:2000015) |
| 0.1 |
0.3 |
GO:0042998 |
positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
| 0.1 |
0.3 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.1 |
0.7 |
GO:0030969 |
mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response(GO:0030969) mRNA splicing, via endonucleolytic cleavage and ligation(GO:0070054) mRNA endonucleolytic cleavage involved in unfolded protein response(GO:0070055) |
| 0.1 |
0.7 |
GO:0043353 |
enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 |
0.1 |
GO:0006370 |
7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.1 |
0.5 |
GO:0043691 |
reverse cholesterol transport(GO:0043691) |
| 0.1 |
0.3 |
GO:1904469 |
positive regulation of tumor necrosis factor secretion(GO:1904469) |
| 0.1 |
0.6 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.1 |
1.1 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.1 |
0.3 |
GO:0006436 |
tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.1 |
0.4 |
GO:0071596 |
ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
| 0.1 |
2.6 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.1 |
0.2 |
GO:1904431 |
positive regulation of t-circle formation(GO:1904431) |
| 0.1 |
1.3 |
GO:0007413 |
axonal fasciculation(GO:0007413) |
| 0.1 |
1.5 |
GO:0032957 |
inositol trisphosphate metabolic process(GO:0032957) |
| 0.1 |
0.6 |
GO:0045607 |
regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 |
1.0 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
1.1 |
GO:0060628 |
regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.1 |
0.8 |
GO:0032484 |
Ral protein signal transduction(GO:0032484) |
| 0.1 |
0.4 |
GO:0009435 |
NAD biosynthetic process(GO:0009435) |
| 0.1 |
0.3 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.1 |
0.2 |
GO:0046479 |
glycolipid catabolic process(GO:0019377) glycosylceramide catabolic process(GO:0046477) glycosphingolipid catabolic process(GO:0046479) |
| 0.1 |
0.3 |
GO:0034729 |
histone H3-K79 methylation(GO:0034729) |
| 0.1 |
0.2 |
GO:0036015 |
response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
| 0.1 |
1.5 |
GO:0019369 |
arachidonic acid metabolic process(GO:0019369) |
| 0.1 |
0.3 |
GO:0019043 |
establishment of viral latency(GO:0019043) |
| 0.1 |
0.2 |
GO:0006549 |
isoleucine metabolic process(GO:0006549) |
| 0.1 |
0.2 |
GO:0003415 |
chondrocyte hypertrophy(GO:0003415) |
| 0.1 |
0.2 |
GO:0072718 |
response to cisplatin(GO:0072718) |
| 0.1 |
0.3 |
GO:0070459 |
prolactin secretion(GO:0070459) |
| 0.1 |
0.1 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.3 |
GO:0042135 |
neurotransmitter catabolic process(GO:0042135) |
| 0.1 |
1.0 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.3 |
GO:1900170 |
regulation of glucocorticoid biosynthetic process(GO:0031946) negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
| 0.1 |
0.5 |
GO:0070417 |
cellular response to cold(GO:0070417) |
| 0.1 |
0.8 |
GO:0015732 |
prostaglandin transport(GO:0015732) |
| 0.1 |
1.3 |
GO:0014898 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 |
0.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.8 |
GO:0034498 |
early endosome to Golgi transport(GO:0034498) |
| 0.1 |
0.2 |
GO:2000256 |
positive regulation of male germ cell proliferation(GO:2000256) |
| 0.1 |
0.1 |
GO:1904468 |
negative regulation of tumor necrosis factor secretion(GO:1904468) |
| 0.1 |
0.4 |
GO:0032815 |
negative regulation of natural killer cell activation(GO:0032815) |
| 0.1 |
0.6 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.2 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.6 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.1 |
0.5 |
GO:0071376 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.4 |
GO:0048312 |
intracellular distribution of mitochondria(GO:0048312) |
| 0.1 |
1.1 |
GO:0038063 |
collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) collagen-activated signaling pathway(GO:0038065) |
| 0.1 |
0.2 |
GO:1902358 |
sulfate transmembrane transport(GO:1902358) |
| 0.1 |
0.4 |
GO:0000972 |
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
| 0.1 |
2.0 |
GO:0061013 |
regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.1 |
0.2 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.4 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.6 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
0.2 |
GO:0042732 |
D-xylose metabolic process(GO:0042732) |
| 0.1 |
0.8 |
GO:0051764 |
actin crosslink formation(GO:0051764) |
| 0.1 |
0.7 |
GO:1904153 |
negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
| 0.1 |
0.2 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.1 |
1.1 |
GO:0006098 |
pentose-phosphate shunt(GO:0006098) |
| 0.1 |
0.4 |
GO:0038032 |
termination of G-protein coupled receptor signaling pathway(GO:0038032) |
| 0.1 |
0.1 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
1.4 |
GO:0071470 |
cellular response to osmotic stress(GO:0071470) |
| 0.1 |
0.5 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.4 |
GO:0036444 |
calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 |
0.1 |
GO:0036292 |
DNA rewinding(GO:0036292) |
| 0.1 |
3.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.2 |
GO:0006083 |
acetate metabolic process(GO:0006083) |
| 0.1 |
0.5 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
2.2 |
GO:0006730 |
one-carbon metabolic process(GO:0006730) |
| 0.1 |
1.0 |
GO:0035269 |
protein O-linked mannosylation(GO:0035269) |
| 0.1 |
1.9 |
GO:0030513 |
positive regulation of BMP signaling pathway(GO:0030513) |
| 0.1 |
1.3 |
GO:0035518 |
histone H2A monoubiquitination(GO:0035518) |
| 0.1 |
0.2 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.1 |
0.2 |
GO:0050747 |
positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 |
0.1 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
1.8 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 |
1.1 |
GO:0021819 |
layer formation in cerebral cortex(GO:0021819) |
| 0.1 |
0.5 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.1 |
0.6 |
GO:0042940 |
D-amino acid transport(GO:0042940) |
| 0.1 |
0.4 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.7 |
GO:0035413 |
positive regulation of catenin import into nucleus(GO:0035413) |
| 0.1 |
0.6 |
GO:0060712 |
spongiotrophoblast layer development(GO:0060712) |
| 0.1 |
0.1 |
GO:0060318 |
definitive erythrocyte differentiation(GO:0060318) |
| 0.1 |
0.3 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.1 |
0.2 |
GO:1990481 |
snoRNA guided rRNA pseudouridine synthesis(GO:0000454) mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 |
1.2 |
GO:0007205 |
protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.1 |
0.4 |
GO:0007405 |
neuroblast proliferation(GO:0007405) |
| 0.1 |
0.2 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.1 |
1.0 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.1 |
0.2 |
GO:0048304 |
positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.1 |
0.7 |
GO:0034497 |
protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 |
0.1 |
GO:2000463 |
modulation of excitatory postsynaptic potential(GO:0098815) positive regulation of excitatory postsynaptic potential(GO:2000463) |
| 0.1 |
0.5 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.1 |
0.6 |
GO:0044801 |
single-organism membrane fusion(GO:0044801) |
| 0.1 |
0.1 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.1 |
GO:0016056 |
rhodopsin mediated signaling pathway(GO:0016056) |
| 0.1 |
0.3 |
GO:1904426 |
positive regulation of GTP binding(GO:1904426) regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904451) positive regulation of hydrogen:potassium-exchanging ATPase activity(GO:1904453) |
| 0.1 |
0.3 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.1 |
1.3 |
GO:0034340 |
response to type I interferon(GO:0034340) |
| 0.1 |
0.3 |
GO:0000379 |
tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 0.1 |
0.4 |
GO:0021523 |
somatic motor neuron differentiation(GO:0021523) protein localization to ciliary transition zone(GO:1904491) |
| 0.1 |
0.1 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.6 |
GO:0021521 |
ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
| 0.1 |
0.2 |
GO:1904417 |
regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.1 |
0.2 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
1.8 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.1 |
1.7 |
GO:0060351 |
cartilage development involved in endochondral bone morphogenesis(GO:0060351) |
| 0.1 |
0.2 |
GO:1901165 |
positive regulation of trophoblast cell migration(GO:1901165) |
| 0.1 |
0.2 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.1 |
0.9 |
GO:0050434 |
positive regulation of viral transcription(GO:0050434) |
| 0.1 |
0.2 |
GO:0071034 |
CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
| 0.1 |
0.2 |
GO:1903204 |
negative regulation of oxidative stress-induced neuron death(GO:1903204) |
| 0.1 |
0.2 |
GO:0060821 |
inactivation of X chromosome by DNA methylation(GO:0060821) |
| 0.1 |
0.5 |
GO:0006390 |
transcription from mitochondrial promoter(GO:0006390) |
| 0.1 |
0.2 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.1 |
0.2 |
GO:0070562 |
regulation of vitamin D receptor signaling pathway(GO:0070562) |
| 0.1 |
0.2 |
GO:1903847 |
regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.1 |
0.2 |
GO:0051798 |
positive regulation of hair follicle development(GO:0051798) |
| 0.1 |
0.2 |
GO:0021506 |
anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.1 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.1 |
0.2 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.1 |
0.5 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.1 |
0.3 |
GO:0002347 |
response to tumor cell(GO:0002347) |
| 0.1 |
0.2 |
GO:0010636 |
positive regulation of mitochondrial fusion(GO:0010636) |
| 0.1 |
0.6 |
GO:0090084 |
negative regulation of inclusion body assembly(GO:0090084) |
| 0.1 |
0.8 |
GO:0045898 |
regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.1 |
0.4 |
GO:0030539 |
male genitalia development(GO:0030539) |
| 0.1 |
0.1 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.1 |
0.3 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
| 0.1 |
0.4 |
GO:0006560 |
proline metabolic process(GO:0006560) |
| 0.1 |
0.4 |
GO:0043589 |
skin morphogenesis(GO:0043589) |
| 0.1 |
0.4 |
GO:2000192 |
negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of fatty acid transport(GO:2000192) |
| 0.1 |
0.2 |
GO:0071600 |
otic vesicle morphogenesis(GO:0071600) |
| 0.1 |
0.5 |
GO:0032876 |
negative regulation of DNA endoreduplication(GO:0032876) |
| 0.1 |
1.0 |
GO:0046513 |
ceramide biosynthetic process(GO:0046513) |
| 0.1 |
0.2 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.1 |
0.2 |
GO:0043312 |
neutrophil degranulation(GO:0043312) |
| 0.1 |
0.7 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.1 |
0.6 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.9 |
GO:0061029 |
eyelid development in camera-type eye(GO:0061029) |
| 0.1 |
0.3 |
GO:0002051 |
osteoblast fate commitment(GO:0002051) |
| 0.1 |
0.2 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.1 |
0.5 |
GO:0071318 |
cellular response to ATP(GO:0071318) |
| 0.1 |
0.2 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.1 |
0.2 |
GO:2000383 |
regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.1 |
2.6 |
GO:0030032 |
lamellipodium assembly(GO:0030032) |
| 0.1 |
0.3 |
GO:0006108 |
malate metabolic process(GO:0006108) |
| 0.0 |
0.2 |
GO:0046886 |
positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.0 |
0.9 |
GO:0006767 |
water-soluble vitamin metabolic process(GO:0006767) |
| 0.0 |
3.7 |
GO:0007601 |
visual perception(GO:0007601) |
| 0.0 |
0.3 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.0 |
0.2 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0045647 |
negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.0 |
0.2 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) |
| 0.0 |
0.2 |
GO:0071453 |
cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
| 0.0 |
0.2 |
GO:0070126 |
mitochondrial translational termination(GO:0070126) |
| 0.0 |
0.6 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.4 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.5 |
GO:0042073 |
intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
| 0.0 |
0.4 |
GO:0036003 |
positive regulation of transcription from RNA polymerase II promoter in response to stress(GO:0036003) |
| 0.0 |
0.1 |
GO:0019085 |
early viral transcription(GO:0019085) |
| 0.0 |
0.1 |
GO:1903599 |
positive regulation of mitophagy(GO:1903599) |
| 0.0 |
0.1 |
GO:0033088 |
negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.0 |
0.2 |
GO:0000187 |
activation of MAPK activity(GO:0000187) |
| 0.0 |
0.6 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.3 |
GO:1900246 |
positive regulation of RIG-I signaling pathway(GO:1900246) |
| 0.0 |
0.5 |
GO:0045792 |
negative regulation of cell size(GO:0045792) |
| 0.0 |
0.1 |
GO:0033484 |
nitric oxide homeostasis(GO:0033484) |
| 0.0 |
0.1 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.0 |
0.6 |
GO:0016926 |
protein desumoylation(GO:0016926) |
| 0.0 |
0.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.2 |
GO:0071955 |
recycling endosome to Golgi transport(GO:0071955) |
| 0.0 |
1.6 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.0 |
0.2 |
GO:2001185 |
regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.0 |
0.3 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.0 |
0.4 |
GO:0006903 |
vesicle targeting(GO:0006903) |
| 0.0 |
1.0 |
GO:0050714 |
positive regulation of protein secretion(GO:0050714) |
| 0.0 |
0.1 |
GO:0001865 |
NK T cell differentiation(GO:0001865) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.4 |
GO:0035970 |
peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.0 |
0.1 |
GO:0010172 |
embryonic body morphogenesis(GO:0010172) |
| 0.0 |
0.4 |
GO:2000780 |
negative regulation of double-strand break repair(GO:2000780) |
| 0.0 |
0.3 |
GO:0090188 |
negative regulation of pancreatic juice secretion(GO:0090188) |
| 0.0 |
0.1 |
GO:0060355 |
positive regulation of cell adhesion molecule production(GO:0060355) |
| 0.0 |
1.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.0 |
0.1 |
GO:0032790 |
ribosome disassembly(GO:0032790) |
| 0.0 |
0.0 |
GO:0006000 |
fructose metabolic process(GO:0006000) |
| 0.0 |
0.2 |
GO:0031214 |
biomineral tissue development(GO:0031214) |
| 0.0 |
0.2 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.4 |
GO:0009072 |
aromatic amino acid family metabolic process(GO:0009072) |
| 0.0 |
0.4 |
GO:0007041 |
lysosomal transport(GO:0007041) |
| 0.0 |
0.2 |
GO:0050965 |
detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
| 0.0 |
0.3 |
GO:0002063 |
chondrocyte development(GO:0002063) |
| 0.0 |
0.0 |
GO:0060216 |
definitive hemopoiesis(GO:0060216) |
| 0.0 |
2.3 |
GO:0030433 |
ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
| 0.0 |
0.2 |
GO:0006166 |
purine ribonucleoside salvage(GO:0006166) |
| 0.0 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.0 |
0.1 |
GO:0030167 |
proteoglycan catabolic process(GO:0030167) regulation of endothelial tube morphogenesis(GO:1901509) |
| 0.0 |
0.2 |
GO:0048262 |
determination of dorsal/ventral asymmetry(GO:0048262) determination of dorsal identity(GO:0048263) |
| 0.0 |
0.2 |
GO:0097324 |
melanocyte migration(GO:0097324) |
| 0.0 |
0.4 |
GO:0070208 |
protein heterotrimerization(GO:0070208) |
| 0.0 |
0.1 |
GO:2000314 |
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.0 |
1.3 |
GO:0034605 |
cellular response to heat(GO:0034605) |
| 0.0 |
0.2 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.0 |
0.1 |
GO:0010701 |
positive regulation of norepinephrine secretion(GO:0010701) |
| 0.0 |
0.3 |
GO:0071340 |
skeletal muscle acetylcholine-gated channel clustering(GO:0071340) |
| 0.0 |
0.7 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.7 |
GO:0008543 |
fibroblast growth factor receptor signaling pathway(GO:0008543) cellular response to fibroblast growth factor stimulus(GO:0044344) |
| 0.0 |
0.2 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 |
0.1 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) |
| 0.0 |
1.2 |
GO:0038061 |
NIK/NF-kappaB signaling(GO:0038061) |
| 0.0 |
0.4 |
GO:0002097 |
tRNA wobble base modification(GO:0002097) |
| 0.0 |
0.3 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.0 |
0.2 |
GO:0030397 |
membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
| 0.0 |
0.3 |
GO:0061635 |
regulation of protein complex stability(GO:0061635) |
| 0.0 |
0.1 |
GO:0070375 |
ERK5 cascade(GO:0070375) |
| 0.0 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.1 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.0 |
0.3 |
GO:0048662 |
negative regulation of smooth muscle cell proliferation(GO:0048662) |
| 0.0 |
0.3 |
GO:0043568 |
positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.0 |
0.5 |
GO:2000001 |
regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 |
0.3 |
GO:0042517 |
positive regulation of tyrosine phosphorylation of Stat3 protein(GO:0042517) |
| 0.0 |
0.7 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) cellular polysaccharide biosynthetic process(GO:0033692) |
| 0.0 |
0.2 |
GO:2000807 |
regulation of synaptic vesicle clustering(GO:2000807) |
| 0.0 |
0.1 |
GO:0001911 |
negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
| 0.0 |
0.2 |
GO:1903361 |
protein localization to basolateral plasma membrane(GO:1903361) |
| 0.0 |
0.3 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.2 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.1 |
GO:0098501 |
polynucleotide dephosphorylation(GO:0098501) |
| 0.0 |
0.1 |
GO:0010728 |
regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
| 0.0 |
0.3 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.0 |
0.2 |
GO:2000310 |
regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
| 0.0 |
0.1 |
GO:1902224 |
cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
| 0.0 |
1.2 |
GO:0032755 |
positive regulation of interleukin-6 production(GO:0032755) |
| 0.0 |
0.4 |
GO:2001241 |
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 |
0.1 |
GO:1904354 |
negative regulation of telomere capping(GO:1904354) |
| 0.0 |
0.1 |
GO:0009301 |
snRNA transcription(GO:0009301) |
| 0.0 |
0.9 |
GO:0071347 |
cellular response to interleukin-1(GO:0071347) |
| 0.0 |
0.1 |
GO:0070863 |
regulation of protein exit from endoplasmic reticulum(GO:0070861) positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.0 |
0.9 |
GO:0006829 |
zinc II ion transport(GO:0006829) |
| 0.0 |
0.3 |
GO:0035330 |
regulation of hippo signaling(GO:0035330) |
| 0.0 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.6 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.2 |
GO:0035562 |
negative regulation of chromatin binding(GO:0035562) |
| 0.0 |
0.5 |
GO:0002089 |
lens morphogenesis in camera-type eye(GO:0002089) |
| 0.0 |
0.4 |
GO:0051281 |
positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.0 |
0.2 |
GO:0043687 |
post-translational protein modification(GO:0043687) |
| 0.0 |
0.2 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.0 |
0.1 |
GO:0036506 |
maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 |
0.1 |
GO:0032066 |
nucleolus to nucleoplasm transport(GO:0032066) |
| 0.0 |
0.2 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.5 |
GO:0045909 |
positive regulation of vasodilation(GO:0045909) |
| 0.0 |
0.2 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.4 |
GO:0052646 |
alditol phosphate metabolic process(GO:0052646) |
| 0.0 |
0.4 |
GO:0018279 |
protein N-linked glycosylation via asparagine(GO:0018279) |
| 0.0 |
0.2 |
GO:0015808 |
L-alanine transport(GO:0015808) |
| 0.0 |
0.1 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.1 |
GO:0035507 |
regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.0 |
0.9 |
GO:0042058 |
regulation of epidermal growth factor receptor signaling pathway(GO:0042058) |
| 0.0 |
0.3 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.6 |
GO:0031115 |
negative regulation of microtubule polymerization(GO:0031115) |
| 0.0 |
0.4 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.5 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.2 |
GO:0014807 |
regulation of somitogenesis(GO:0014807) |
| 0.0 |
0.7 |
GO:0046854 |
phosphatidylinositol phosphorylation(GO:0046854) |
| 0.0 |
0.1 |
GO:0071774 |
response to fibroblast growth factor(GO:0071774) |
| 0.0 |
0.4 |
GO:0033866 |
coenzyme A biosynthetic process(GO:0015937) nucleoside bisphosphate biosynthetic process(GO:0033866) ribonucleoside bisphosphate biosynthetic process(GO:0034030) purine nucleoside bisphosphate biosynthetic process(GO:0034033) |
| 0.0 |
0.7 |
GO:0018345 |
protein palmitoylation(GO:0018345) |
| 0.0 |
0.3 |
GO:0051103 |
DNA ligation involved in DNA repair(GO:0051103) |
| 0.0 |
0.2 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.0 |
0.2 |
GO:0006851 |
mitochondrial calcium ion transport(GO:0006851) |
| 0.0 |
0.3 |
GO:0090140 |
regulation of mitochondrial fission(GO:0090140) |
| 0.0 |
0.1 |
GO:0060059 |
embryonic retina morphogenesis in camera-type eye(GO:0060059) |
| 0.0 |
0.1 |
GO:0000480 |
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 |
0.5 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0044539 |
long-chain fatty acid import(GO:0044539) |
| 0.0 |
0.1 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) |
| 0.0 |
0.8 |
GO:0051647 |
nucleus localization(GO:0051647) |
| 0.0 |
0.5 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.3 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.0 |
0.2 |
GO:0098532 |
histone H3-K27 trimethylation(GO:0098532) |
| 0.0 |
0.8 |
GO:0050729 |
positive regulation of inflammatory response(GO:0050729) |
| 0.0 |
0.4 |
GO:0097006 |
regulation of plasma lipoprotein particle levels(GO:0097006) |
| 0.0 |
0.9 |
GO:0030521 |
androgen receptor signaling pathway(GO:0030521) |
| 0.0 |
0.5 |
GO:1901897 |
regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.0 |
0.1 |
GO:2000821 |
regulation of grooming behavior(GO:2000821) |
| 0.0 |
0.2 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.0 |
0.4 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) |
| 0.0 |
0.4 |
GO:0010718 |
positive regulation of epithelial to mesenchymal transition(GO:0010718) |
| 0.0 |
0.2 |
GO:0051560 |
mitochondrial calcium ion homeostasis(GO:0051560) |
| 0.0 |
0.3 |
GO:0033344 |
cholesterol efflux(GO:0033344) |
| 0.0 |
0.1 |
GO:0032703 |
negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 |
0.3 |
GO:0044804 |
nucleophagy(GO:0044804) |
| 0.0 |
0.1 |
GO:0010998 |
regulation of translational initiation by eIF2 alpha phosphorylation(GO:0010998) regulation of translational initiation in response to stress(GO:0043558) |
| 0.0 |
0.3 |
GO:0006635 |
fatty acid beta-oxidation(GO:0006635) |
| 0.0 |
0.3 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.0 |
0.2 |
GO:0032060 |
bleb assembly(GO:0032060) |
| 0.0 |
0.1 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.0 |
0.2 |
GO:0060394 |
negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
| 0.0 |
0.3 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 |
3.8 |
GO:0008360 |
regulation of cell shape(GO:0008360) |
| 0.0 |
1.4 |
GO:0007156 |
homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 |
0.3 |
GO:0050909 |
sensory perception of taste(GO:0050909) |
| 0.0 |
0.3 |
GO:0006379 |
mRNA cleavage(GO:0006379) |
| 0.0 |
0.0 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.4 |
GO:0038083 |
peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.0 |
0.2 |
GO:0097369 |
sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.0 |
0.5 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.0 |
0.9 |
GO:0051492 |
regulation of stress fiber assembly(GO:0051492) |
| 0.0 |
0.3 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:0030042 |
actin filament depolymerization(GO:0030042) |
| 0.0 |
1.1 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.2 |
GO:0014823 |
response to activity(GO:0014823) |
| 0.0 |
0.3 |
GO:0034219 |
carbohydrate transmembrane transport(GO:0034219) |
| 0.0 |
0.2 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.0 |
1.3 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.2 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 0.0 |
0.7 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.1 |
GO:0043654 |
recognition of apoptotic cell(GO:0043654) |
| 0.0 |
0.1 |
GO:2000983 |
regulation of ATP citrate synthase activity(GO:2000983) negative regulation of ATP citrate synthase activity(GO:2000984) |
| 0.0 |
0.1 |
GO:1903587 |
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
| 0.0 |
0.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.2 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.0 |
GO:0033233 |
regulation of protein sumoylation(GO:0033233) positive regulation of protein sumoylation(GO:0033235) |
| 0.0 |
0.1 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.0 |
0.1 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.5 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.0 |
GO:0036158 |
outer dynein arm assembly(GO:0036158) |
| 0.0 |
0.0 |
GO:0035729 |
response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
| 0.0 |
0.2 |
GO:0010457 |
centriole-centriole cohesion(GO:0010457) |
| 0.0 |
0.1 |
GO:0006264 |
mitochondrial DNA replication(GO:0006264) |
| 0.0 |
0.2 |
GO:1900026 |
positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
| 0.0 |
0.3 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.2 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.1 |
GO:0000290 |
deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 |
0.3 |
GO:0080171 |
lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
| 0.0 |
0.0 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.0 |
0.1 |
GO:0051823 |
regulation of synapse structural plasticity(GO:0051823) |
| 0.0 |
0.2 |
GO:0010470 |
regulation of gastrulation(GO:0010470) |
| 0.0 |
0.1 |
GO:0006895 |
Golgi to endosome transport(GO:0006895) |
| 0.0 |
0.0 |
GO:0060729 |
intestinal epithelial structure maintenance(GO:0060729) |
| 0.0 |
0.1 |
GO:0072520 |
seminiferous tubule development(GO:0072520) |
| 0.0 |
0.0 |
GO:0071105 |
response to interleukin-11(GO:0071105) |
| 0.0 |
0.0 |
GO:0071260 |
cellular response to mechanical stimulus(GO:0071260) |
| 0.0 |
0.1 |
GO:0006729 |
tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.0 |
0.1 |
GO:0072578 |
neurotransmitter-gated ion channel clustering(GO:0072578) |
| 0.0 |
0.0 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.0 |
0.1 |
GO:0034088 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.0 |
0.1 |
GO:2000810 |
regulation of bicellular tight junction assembly(GO:2000810) |
| 0.0 |
0.2 |
GO:0031936 |
negative regulation of chromatin silencing(GO:0031936) |
| 0.0 |
0.3 |
GO:0032981 |
NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.0 |
0.3 |
GO:0007031 |
peroxisome organization(GO:0007031) |
| 0.0 |
0.1 |
GO:0010640 |
regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
| 0.0 |
0.1 |
GO:1904294 |
positive regulation of ERAD pathway(GO:1904294) |
| 0.0 |
0.1 |
GO:0045604 |
regulation of epidermal cell differentiation(GO:0045604) |
| 0.0 |
0.3 |
GO:0050919 |
negative chemotaxis(GO:0050919) |
| 0.0 |
0.0 |
GO:0032474 |
otolith morphogenesis(GO:0032474) otolith development(GO:0048840) |
| 0.0 |
0.1 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.2 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.1 |
GO:0051571 |
positive regulation of histone H3-K4 methylation(GO:0051571) |
| 0.0 |
0.1 |
GO:0051601 |
exocyst localization(GO:0051601) |
| 0.0 |
0.1 |
GO:0009062 |
fatty acid catabolic process(GO:0009062) |
| 0.0 |
0.1 |
GO:0030812 |
negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
| 0.0 |
0.0 |
GO:0010387 |
COP9 signalosome assembly(GO:0010387) |
| 0.0 |
0.2 |
GO:0040034 |
regulation of development, heterochronic(GO:0040034) |
| 0.0 |
0.1 |
GO:0034244 |
negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 |
0.2 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.0 |
0.4 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.0 |
0.1 |
GO:0043154 |
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) negative regulation of cysteine-type endopeptidase activity(GO:2000117) |
| 0.0 |
0.2 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.2 |
GO:0015844 |
monoamine transport(GO:0015844) |
| 0.0 |
0.0 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.1 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.0 |
0.2 |
GO:0051180 |
vitamin transport(GO:0051180) |
| 0.0 |
0.2 |
GO:0015908 |
fatty acid transport(GO:0015908) |
| 0.0 |
0.0 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.0 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.0 |
0.1 |
GO:0035337 |
fatty-acyl-CoA metabolic process(GO:0035337) |
| 0.0 |
0.4 |
GO:0006334 |
nucleosome assembly(GO:0006334) |
| 0.0 |
0.3 |
GO:0016574 |
histone ubiquitination(GO:0016574) |
| 0.0 |
0.1 |
GO:0042866 |
L-serine metabolic process(GO:0006563) pyruvate biosynthetic process(GO:0042866) |
| 0.0 |
0.2 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.0 |
0.3 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.0 |
0.0 |
GO:0002949 |
tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.0 |
0.1 |
GO:1903799 |
negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
| 0.0 |
0.0 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.0 |
0.0 |
GO:0038030 |
non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.0 |
0.3 |
GO:0045766 |
positive regulation of angiogenesis(GO:0045766) |
| 0.0 |
0.0 |
GO:0019919 |
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
